
Life Science Logistics expands warehouse capacity, again
Firm has quintupled its Indianapolis facility over two years
Another 132,000 sq. ft. of capacity is being added to the Indianapolis facility, following 
According to Richard Beeny, CEO of LSL, the fast-growing market is demanding more regulated storage capacity and supply chain solutions, and LSL is simply being responsive. He adds that the central location of the Indianapolis facility is a draw for many pharmaceutical and medical device companies looking for distribution and accessibility efficiencies. LSL has four US locations (Dallas, Indianapolis, Baltimore and Atlanta, which will now total 1.6 million sq. ft of capacity exclusively for life sciences products. In addition to the storage, it offers 3PL logistics services, including distribution, order to cash and regulatory compliance.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





